Gender research in the national institute on drug abuse national treatment clinical trials network: A summary of findings

American Journal of Drug and Alcohol Abuse

Volumn 37, Issue 5, 2011, Pages 301-312

  Greenfield, Shelly F ^a,b   Rosa, Carmen ^c   Putnins, Susan I ^a   Green, Carla A ^d   Brooks, Audrey J ^e   Calsyn, Donald A ^f   Cohen, Lisa R ^g   Erickson, Sarah ^h   Gordon, Susan M ⁱ   Haynes, Louise ^j   Killeen, Therese ^k   Miele, Gloria ^g   Tross, Susan ^g   Winhusen, Theresa ^l  

^a MCLEAN HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c NATIONAL INSTITUTE ON DRUG ABUSE   (United States)

^d CENTER FOR HEALTH RESEARCH   (United States)

^e University of Arizona   (United States)

^f UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^g NEW YORK STATE PSYCHIATRIC INSTITUTE   (United States)

^h UNIVERSITY OF NEW MEXICO SCHOOL OF MEDICINE   (United States)

ⁱ Belmont Ctr for Compreh Treatment   (United States)

^j Morris Village Alcohol and Drug Treatment Center   (United States)

^k MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^l UNIVERSITY OF CINCINNATI   (United States)

more..

Author keywords

Co occurring disorders; Eating disorders; Gender differences; HIV prevention; HIV risk behaviors; Pregnant women; PTSD; Substance abuse treatment; Substance use disorders; Women

Indexed keywords

METHADONE;

ALCOHOL CONSUMPTION; ANGER; ARTICLE; BINGE EATING DISORDER; CHILD ABUSE; COMMUNICATION SKILL; DECISION MAKING; DEPRESSION; DISEASE SEVERITY; DRUG DEPENDENCE TREATMENT; EATING DISORDER; FUNDING; GOVERNMENT; HEALTH EDUCATION; HELP SEEKING BEHAVIOR; HIGH RISK BEHAVIOR; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INTRAVENOUS DRUG ABUSE; IRRITABILITY; MEDICAL HISTORY; MENTAL DISEASE; MOTIVATION; ORGANIZATION AND MANAGEMENT; OUTCOME ASSESSMENT; PARTNER VIOLENCE; PATIENT PARTICIPATION; POST HOC ANALYSIS; POSTTRAUMATIC STRESS DISORDER; PREGNANCY; PSYCHOTRAUMA; RANDOMIZED CONTROLLED TRIAL (TOPIC); REIMBURSEMENT; RESPONSIBILITY; RISK ASSESSMENT; RISK REDUCTION; SAFE SEX; SAFETY; SCREENING; SEX DIFFERENCE; SEX ROLE; SEXUAL BEHAVIOR; STATISTICAL MODEL; SUBSTANCE ABUSE; TREATMENT OUTCOME; UNSAFE SEX;

FEMALE; HIV INFECTIONS; HUMANS; MALE; MULTICENTER STUDIES AS TOPIC; NATIONAL INSTITUTE ON DRUG ABUSE (U.S.); RANDOMIZED CONTROLLED TRIALS AS TOPIC; RESEARCH DESIGN; RISK-TAKING; SEX FACTORS; SUBSTANCE-RELATED DISORDERS; TRANSLATIONAL MEDICAL RESEARCH; UNITED STATES;

EID: 80052237574     PISSN: 00952990     EISSN: 10979891     Source Type: Journal    
DOI: 10.3109/00952990.2011.596875     Document Type: Article

References (44)

1. Hanson GR, Leshner AI, Tai B. Putting drug abuse research to use in real-life settings. J Subst Abuse Treat 2002; 23(2): 69-70. (Pubitemid 36151687)
2. Tai B, Straus MM, Liu D, Sparenborg S, Jackson R, McCarty D. The first decade of the national drug abuse treatment clinical trials network: Bridging the gap between research and practice to improve drug abuse treatment. J Subst Abuse Treat 2010; 38(Suppl. 1):S4-S13.
3. Leshner AI. Experimental and clinical psychopharmacology: National Institute on Drug Abuses clinical research agenda. Exp Clin Psychopharmacol 2002; 10(3):159-161. (Pubitemid 34919926)
4. Marrocco A, Stewart DE. Weve come a long way, maybe: Recruitment of women and analysis of results by sex in clinical research. J Womens Health Gend Based Med 2001; 10(2):175-179. (Pubitemid 32243837)
5. Uhl K, Parekh A, Kweder S. Females in clinical studies: Where are we going? Clin Pharmacol Ther 2007; 81(4): 600-602. (Pubitemid 46452313)
6. Vidaver RM, Lafleur B, Tong C, Bradshaw R, Marts SA. Women subjects in NIH-funded clinical research literature: Lack of progress in both representation and analysis by sex. J Womens Health Gend Based Med 2000; 9(5):495-504. (Pubitemid 30426926)
7. Nieuwenhoven L, Klinge I. Scientific excellence in applying sex- and gender-sensitive methods in biomedical and health research. J Womens Health (Larchmt) 2010; 19(2): 313-321.
8. Becker JB, Arnold AP, Berkley KJ, Blaustein JD, Eckel LA, Hampson E, Herman JP, Marts S, Sadee W, Steiner M, Taylor J, Young E. Strategies and methods for research on sex differences in brain and behavior. Endocrinology 2005; 146(4):1650-1673. (Pubitemid 40396871)
9. Greenfield SF, Brooks AJ, Gordon SM, Green CA, Kropp F, McHugh RK, Lincoln M, Hien D, Miele GM. Substance abuse treatment entry, retention, and outcome in women: A review of the literature. Drug Alcohol Depend 2007; 86(1): 1-21. (Pubitemid 44708526)
10. Brooks AJ, Meade CS, Potter JS, Loknygina Y, Calsyn D, Greenfield SF. Gender differences in rates and correlates of HIV risk behaviors among drug dependent individuals. Susbt Use Misuse 2010; 45(14):2444-2469.
11. Wells EA, Saxon AJ, Calsyn DA, Jackson TR, Donovan DM. Study results from the clinical trials networks first 10 years: Where do they lead? J Subst Abuse Treat 2010; 38(Suppl. 1):S14-S30.
12. Cohen LR, Greenfield SF, Gordon S, Killeen T, Jiang H, Zhang Y, Hien DA. Survey of eating disorder symptoms among women in treatment of substance abuse. Am J Addict 2010; 19(3):245-251.
13. Erickson S, Tonigan J. Trauma and intravenous drug use among pregnant alcohol/other drug abusing women: Factors in predicting child abuse potential. Alcsm Treat Quart 2008; 26(3):313-332.
14. Gordon SM, Johnson JA, Greenfield SF, Cohen L, Killeen T, Roman PM. Assessment and treatment of co-occurring eating disorders in publicly funded addiction treatment programs. Psychiatr Serv 2008; 59(9):1056-1059.
15. Killeen T, Greenfield SF, Bride BE, Cohen L, Gordon SM, Roman PM. Treatment of co-occurring eating disorders in privately funded addiction treatment programs. Am J Addict 2011; 20(3):205-211.
16. Winhusen T, Kropp F, Babcock D, Hague D, Erickson SJ, Renz C, Rau L, Lewis D, Leimberger J, Somoza E. Motivational enhancement therapy to improve treatment utilization and outcome in pregnant substance users. J Subst Abuse Treat 2008; 35(2):161-173.
17. Hien DA, Wells EA, Jiang H, Suarez-Morales L, Campbell AN, Cohen LR, Miele GM, Killeen T, Brigham GS, Zhang Y, Hansen C, Hodgkins C, Hatch-Maillette M, Brown C, Kulaga A, Kristman-Valente A, Chu M, Sage R, Robinson JA, Liu D, Nunes EV. Multisite randomized trial of behavioral interventions for women with co-occurring PTSD and substance use disorders. J Consult Clin Psychol 2009; 77:607-619.
18. Calsyn DA, Hatch-Maillette M, Tross S, Doyle SR, Crits- Christoph P, Song YS, Harrer JM, Lalos G, Berns SB. Motivational and skills training HIV/sexually transmitted infection sexual risk reduction groups for men. J Subst Abuse Treat 2009; 37(2):138-150.
19. Tross S, Campbell AN, Cohen LR, Calsyn D, Pavlicova M, Miele GM, Hu MC, Haynes L, Nugent N, Gan W, Hatch- Maillette M, Mandler R, McLaughlin P, El-Bassel N, Crits- Christoph P, Nunes EV. Effectiveness of HIV/STD sexual risk reduction groups for women in substance abuse treatment programs: Results of NIDA clinical trials network trial. J Acquir Immune Defic Syndr 2008; 48(5):581-589.
20. Ondersma SJ, Winhusen T, Erickson SJ, Stine SM, Motivation Enhancement WY. Therapy with pregnant substanceabusing women: Does baseline motivation moderate efficacy? Drug Alcohol Depend 2009; 101(1-2):74-79.
21. Brigham G, Winhusen T, Lewis D, Kropp F. Incentives for retention of pregnant substance users: A secondary analysis. J Subst Abuse Treat 2010; 38(1):90-95.
22. Hien DA, Jiang H, Campbell AN, Hu MC, Miele GM, Cohen LR, Brigham GS, Capstick C, Kulaga A, Robinson J, Suarez- Morales L, Nunes EV. Do treatment improvements in PTSD severity affect substance use outcomes? A secondary analysis from a randomized clinical trial in NIDAs clinical trials network. Am J Psychiatry 2010; 167(1):95-101.
23. Killeen TK, Hien D, Campbell A, Brown C, Hansen C, Jiang H, Kristman-Valente A, Neuenfeldt C, Rocz-de la Luz N, Sampson R, Suarez-Morales L, Wells E, Brigham G, Nunes E. Adverse events in an integrated trauma-focused intervention for women in community substance abuse treatment. J Subst Abuse Treat 2008; 35(3):304-311.
24. Hien DA, Campbell AN, Killeen T, Hu MC, Hansen C, Jiang H, Hatch-Maillette M, Miele GM, Cohen LR, Gan W, Resko SM, Dibono M, Wells EA, Nunes EV. The impact of traumafocused group therapy upon HIV sexual risk behaviors in the NIDA Clinical Trials Network "Women and Trauma" multisite study. AIDS Behav 2010; 14:421-430.
25. Rinehart DJ, Becker MA, Buckley PR, Dailey K, Reichardt CS, Graeber C, VanDeMark NR, Brown E. The relationship between mothers child abuse potential and current mental health symptoms: Implications for screening and referral. J Behav Health Serv Res 2005; 32(2):155-166. (Pubitemid 40525299)
26. Nair P, Schuler ME, Black MM, Kettinger L, Harrington D. Cumulative environmental risk in substance abusing women: Early intervention, parenting stress, child abuse potential and child development. Child Abuse Negl 2003; 27(9):997-1017. (Pubitemid 37205037)
27. Najavits LM, Weiss RD, Shaw SR, Muenz LR. "Seeking safety": Outcome of a new cognitive-behavioral psychotherapy for women with posttraumatic stress disorder and substance dependence. J Trauma Stress 1998; 11(3): 437-456. (Pubitemid 28354340)
28. Najavits LM. Seeking Safety: A. Treatment Manual for PTSD and Substance Abuse. New York, NY: Guilford Press, 2002.
29. Chilcoat HD, Breslau N. Posttraumatic stress disorder and drug disorders: Testing causal pathways. Arch Gen Psychiatry 1998; 55(10):913-917. (Pubitemid 28465781)
30. Franko DL, Dorer DJ, Keel PK, Jackson S, Manzo MP, Herzog DB. How do eating disorders and alcohol use disorder influence each other? Int J Eat Disord 2005; 38(3):200-207. (Pubitemid 41618959)
31. Knudsen HK, Ducharme LJ, Roman PM. Early adoption of buprenorphine in substance abuse treatment centers: Data from the private and public sectors. J Subst Abuse Treat 2006; 30(4):363-373. (Pubitemid 43729149)
32. Knudsen HK, Ducharme LJ, Roman PM. The use of antidepressant medications in substance abuse treatment: The public-private distinction, organizational compatibility, and the environment. J Health Soc Behav 2007; 48(2): 195-210.
33. Calsyn DA, Crits-Christoph P, Hatch-Maillette MA, Doyle SR, Song YS, Coyer S, Pelta S. Reducing sex under the influence of drugs or alcohol for patients in substance abuse treatment. Addiction 2010; 105(1):100-108.
34. Darke S. Self-report among injecting drug users: A review. Drug Alcohol Depend 1998; 51(3):253-263, discussion 267-268.
35. Gadalla T, Piran N. Eating disorders and substance abuse in Canadian men and women: A national study. Eat Disord 2007; 15(3):189-203. (Pubitemid 46845573)
36. NIH . NIH Policy and Guidelines on the Inclusion of Women and Minorities as Subjects in Clinical Research, 2001. Availabe at http://grants.nih.gov/ grants/funding/women-min/guidelines-amended-10-2001.htm. Last accessed on July 4, 2011.
37. Woolf SH. The power of prevention and what it requires. J Am Med Assoc 2008; 299(20):211-213.
38. Institute of Medicine, Lamb S, Greenlick MR, McCarty D, eds. Bridging the Gap Between Practice and Research: Forging Partnerships with Community-Based Drug and Alcohol Treatment. Washington, DC: National Academy Press, 1998.
39. Allen SS, Bade T, Center B, Finstad D, Hatsukami D. Menstrual phase effects on smoking relapse. Addiction 2008; 103(5):809-821. (Pubitemid 351537675)
40. Franklin TR, Ehrman R, Lynch KG, Harper D, Sciortino N, OBrien CP, Childress AR. Menstrual cycle phase at quit date predicts smoking status in an NRT treatment trial: A retrospective analysis. J Womens Health (Larchmt) 2008; 17(2):287-292. (Pubitemid 351631249)
41. Terner JM, de Wit H. Menstrual cycle phase and responses to drugs of abuse in humans. Drug Alcohol Depend 2006; 84(1):1-13. (Pubitemid 44107639)
42. Haug NA, Shopshire M, Tajima B, Gruber V, Guydish J. Adoption of evidence-based practices among substance abuse treatment providers. J Drug Educ 2008; 38(2):181-192.
43. Herbeck DM, Hser YI, Teruya C. Empirically supported substance abuse treatment approaches: A survey of treatment providers perspectives and practices. Addict Behav 2008; 33(5):699-712.
44. Holderness CC, Brooks-Gunn J,Warren MP. Co-morbidity of eating disorders and substance abuse: Review of the literature. Int J Eat Disord 1994; 16(1):1-34. (Pubitemid 24200157)